Research-stage review
We identify protectable inventions and additional data needs from results and disclosure plans.
BIO & HEALTHCARE
Bio & Healthcare
We align the timing of protection with the path to commercialization.
BiotechnologyMedical devicesDigital health
OVERVIEW
Protection designed around what comes next.
Experimental data, publication, collaboration, clinical and regulatory schedules inform protection for compounds, uses, diagnostics, devices and digital health.
Discuss this serviceCAPABILITIES
Support where your business needs it
From a focused filing to long-term portfolio and dispute advice, the scope is tailored to the matter.
Claim architecture
Compounds, compositions, uses, manufacturing, diagnostics and devices are organized around product plans.
Collaboration
Inventorship, ownership, filing and publication procedures are reviewed for joint and commissioned R&D.
Global strategy
Jurisdiction priorities reflect examination practice, target markets and commercialization timing.
ENGAGEMENT
Clear context at every stage
Details vary by matter, but key decisions and next actions remain transparent.
Understand
We identify objectives, timing, disclosure and available materials.
Analyze
We assess protectability, risk and viable paths.
Align
We align on scope, timing, expected cost and priorities.
Execute
We execute the strategy and manage follow-up as circumstances evolve.
FAQ
Frequently asked questions
These are general answers. Advice may differ after the facts and applicable law are reviewed.
Is complete experimental data required?
The necessary level depends on the invention and desired scope. We assess what current results support and what should be added.
Should we consult before submitting a paper?
Abstracts, papers and conference presentations may be public disclosures, so filing timing should be reviewed first.
Who files joint research results?
Actual inventive contribution and contractual ownership provisions both need review.
START A CONVERSATION